It’s been an interesting ride with EMV, as it is with all pre-revenue companies. I’ve got a significant holding at sub-$0.25 that I’ve held since IPO, and I am absolutely considering “betting the house” so to speak.
Being impactful with novel medical technology takes time, sure. But most importantly it depends on good data and good relationships…tick and tick.
If you’re nervous by the very reasonable and very overdue market correction, then please sell me your shares. It will be a bumpy road the next 12-36 months.
A very, very happy holder. And GLTAH.
It’s been an interesting ride with EMV, as it is with all...
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
-0.005(0.26%) |
Mkt cap ! $165.4M | |||
| Open | High | Low | Value | Volume |
| $1.93 | $1.94 | $1.90 | $32.16K | 16.74K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2617 | $1.91 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.94 | 5790 | 2 |
View Market Depth
| Last trade - 15.51pm 15/11/2024 (20 minute delay) ? |
| EMV (ASX) Chart |